Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia

被引：29
|
作者：
Ulloa, Erlinda R. [1 ,2 ]
Singh, Kavindra, V [3 ,4 ]
Geriak, Matthew [5 ]
Haddad, Fadi [6 ]
Murray, Barbara E. [3 ,4 ]
Nizet, Victor [1 ,7 ]
Sakoulas, George [1 ,5 ]
机构：
[1] Univ Calif San Diego, Sch Med, Dept Pediat, Collaborat Halt Antibiot Resistant Microbes, La Jolla, CA 92093 USA
[2] Childrens Hosp Philadelphia, Dept Pediat, Div Infect Dis, Philadelphia, PA 19104 USA
[3] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Internal Med, Div Infect Dis, Houston, TX 77030 USA
[4] Univ Texas Hlth Sci Ctr Houston, Ctr Antimicrobial Resistance & Microbial Genom, McGovern Med Sch, Houston, TX 77030 USA
[5] Sharp Mem Hosp & Rehabil Ctr, San Diego, CA USA
[6] Sharp Grossmont Hosp, La Mesa, CA USA
[7] Univ Calif San Diego, Skaggs Sch Pharm, La Jolla, CA 92093 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2020年 / 71卷 / 06期
基金：
美国国家卫生研究院;
关键词：
Staphylococcus aureus; bacteremia; endocarditis; cefazolin; ertapenem; PENICILLIN-BINDING PROTEINS; ENDOCARDITIS; MANAGEMENT; OXACILLIN; SYNERGY;
D O I：
10.1093/cid/ciz995
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Cefazolin and ertapenem combination therapy was used successfully to salvage 11 cases (6 endocarditis) of persistent methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia, including immediate clearance (<= 24 hours) in 8 cases. While in vitro synergy was modest, cefazolin plus ertapenem exhibited synergistic action in a rat model of MSSA endocarditis. The combination of cefazolin and ertapenem provides potent in vivo activity against MSSA beyond what is predicted in vitro and warrants further clinical study in the treatment of refractory MSSA bacteremia and endocarditis. Cefazolin and ertapenem combination therapy yielded profound clinical success in 11 severe methicillin-susceptible Staphylococcus aureus infections with high bacterial densities (6 endocarditis), as demonstrated by rapid bacteremia clearance. Enhanced efficacy was also observed in a rat endocarditis model.
引用
收藏
页码：1413 / 1418
页数：6
相关论文
共 50 条
  • [31] Post-treatment outcomes of ceftriaxone versus antistaphylococcal penicillins or cefazolin for definitive therapy of methicillin-susceptible Staphylococcus aureus bacteremia
    Zachary A. Yetmar
    Ryan B. Khodadadi
    John Raymond Go
    Supavit Chesdachai
    Omar M. Abu Saleh
    European Journal of Clinical Microbiology & Infectious Diseases, 2023, 42 : 423 - 430
  • [32] Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia
    Sakoulas, George
    Olson, Joshua
    Yim, Juwon
    Singh, Niedita B.
    Kumaraswamy, Monika
    Quach, Diana T.
    Rybak, Michael J.
    Pogliano, Joseph
    Nizet, Victor
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (11) : 6609 - 6618
  • [33] Two cases of refractory methicillin-susceptible staphylococcus aureus endocarditis responsive to ertapenem
    Abhinav Karan
    Pranitha Chekka
    Pramod Reddy
    Journal of Geriatric Cardiology, 2023, 20 (11) : 829 - 831
  • [34] Two cases of refractory methicillin-susceptible staphylococcus aureus endocarditis responsive to ertapenem
    Karan, Abhinav
    Chekka, Pranitha
    Reddy, Pramod
    JOURNAL OF GERIATRIC CARDIOLOGY, 2023, 20 (11) : 829 - 831
  • [35] Two cases of refractory methicillin-susceptible staphylococcus aureus endocarditis responsive to ertapenem
    Abhinav Karan
    Pranitha Chekka
    Pramod Reddy
    Journal of Geriatric Cardiology, 2023, 20 (11) : 829 - 831
  • [36] Outpatient parenteral antimicrobial therapy for the treatment of methicillin-susceptible Staphylococcus aureus: a comparison of cefazolin and ceftriaxone
    S. A. Winans
    A. M. Luce
    R. Hasbun
    Infection, 2013, 41 : 769 - 774
  • [37] Outpatient parenteral antimicrobial therapy for the treatment of methicillin-susceptible Staphylococcus aureus: a comparison of cefazolin and ceftriaxone
    Winans, S. A.
    Luce, A. M.
    Hasbun, R.
    INFECTION, 2013, 41 (04) : 769 - 774
  • [38] High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia
    Maria Aguado, Jose
    San-Juan, Rafael
    Lalueza, Antonio
    Sanz, Francisca
    Rodriguez-Otero, Joaquin
    Gomez-Gonzalez, Carmen
    Chaves, Fernando
    EMERGING INFECTIOUS DISEASES, 2011, 17 (06) : 1099 - 1102
  • [39] Cefazolin Inoculum Effect and Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children
    McNeil, J. Chase
    Sommer, Lauren M.
    Boyle, Mary
    Hogan, Patrick
    Vallejo, Jesus G.
    Hulten, Kristina G.
    Flores, Anthony R.
    Kaplan, Sheldon L.
    Fritz, Stephanie
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [40] Ceftriaxone for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia: a matter of dosages?
    Stefano Di Bella
    Milo Gatti
    Luigi Principe
    European Journal of Clinical Microbiology & Infectious Diseases, 2023, 42 : 917 - 918
12345